TrademarkDir
PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
LIVE

Serial Number

87982664

Owner

Plexxikon Inc.

Attorney

Harold Milstein

First Use Date

Oct 10, 2019

Filing Date

Jun 23, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY Trademark

Serial Number: 87982664 • Registration: 6008629

PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY is a trademark filed by Plexxikon Inc. on June 23, 2017. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Plexxikon Inc. (8 trademarks)

91 Bolivar Drive
Berkeley, CA 94710

Entity Type: 03

Trademark Details

Filing Date

June 23, 2017

Registration Date

March 10, 2020

First Use Anywhere

October 10, 2019

First Use in Commerce

October 10, 2019

Published for Opposition

November 14, 2017

Goods & Services

Product development research, product development, and product development consultation regarding pharmaceutical, biological and biotechnological products; Pharmaceutical research and development services; medical research and development services in the field of treatments for cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 10, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2020 R.PR
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 4, 2020 MDSC
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 4, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 3, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 3, 2020 SUPC
DIVISIONAL PROCESSING COMPLETE
Feb 3, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 3, 2020 AITU
USE AMENDMENT FILED
Jan 6, 2020 IUAF
DIVISIONAL REQUEST RECEIVED
Jan 6, 2020 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jan 6, 2020 ERTD
TEAS STATEMENT OF USE RECEIVED
Jan 6, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 4, 2020 EXRA
SOU EXTENSION 4 GRANTED
Jan 2, 2020 EX4G
SOU EXTENSION 4 FILED
Jan 2, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 2, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 3, 2019 EXRA
SOU EXTENSION 3 GRANTED
Jul 1, 2019 EX3G
SOU EXTENSION 3 FILED
Jul 1, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 1, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jan 4, 2019 EX2G
SOU EXTENSION 2 FILED
Jan 4, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 4, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jul 5, 2018 EX1G
SOU EXTENSION 1 FILED
Jul 5, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 5, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 9, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 25, 2017 NONP
ASSIGNED TO LIE
Oct 9, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 22, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 22, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 22, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 22, 2017 CNEA
ASSIGNED TO EXAMINER
Sep 21, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 1, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2017 NWOS
NEW APPLICATION ENTERED
Jun 27, 2017 NWAP

Related Trademarks

More from this Owner

PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE logo

PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE

PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE logo

PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE

PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE logo

PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE

PLEXXIKON

PLEXXIKON

PLEXXIKON

PLEXXIKON

PLEXXIKON

PLEXXIKON